» Articles » PMID: 34234299

Theranostic Cells: Emerging Clinical Applications of Synthetic Biology

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2021 Jul 8
PMID 34234299
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Synthetic biology seeks to redesign biological systems to perform novel functions in a predictable manner. Recent advances in bacterial and mammalian cell engineering include the development of cells that function in biological samples or within the body as minimally invasive diagnostics or theranostics for the real-time regulation of complex diseased states. Ex vivo and in vivo cell-based biosensors and therapeutics have been developed to target a wide range of diseases including cancer, microbiome dysbiosis and autoimmune and metabolic diseases. While probiotic therapies have advanced to clinical trials, chimeric antigen receptor (CAR) T cell therapies have received regulatory approval, exemplifying the clinical potential of cellular therapies. This Review discusses preclinical and clinical applications of bacterial and mammalian sensing and drug delivery platforms as well as the underlying biological designs that could enable new classes of cell diagnostics and therapeutics. Additionally, we describe challenges that must be overcome for more rapid and safer clinical use of engineered systems.

Citing Articles

biGMamAct: efficient CRISPR/Cas9-mediated docking of large functional DNA cargoes at the locus.

Pelosse M, Marcia M Synth Biol (Oxf). 2025; 10(1):ysaf003.

PMID: 40065842 PMC: 11891445. DOI: 10.1093/synbio/ysaf003.


Population-level amplification of gene regulation by programmable gene transfer.

Son H, Hamrick G, Shende A, Kim K, Yang K, Huang T Nat Chem Biol. 2025; .

PMID: 39779901 DOI: 10.1038/s41589-024-01817-9.


CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors.

Tian Y, Zhang L, Ping Y, Zhang Z, Yao C, Shen C Cancer Immunol Immunother. 2025; 74(2):55.

PMID: 39751840 PMC: 11699016. DOI: 10.1007/s00262-024-03909-w.


Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy.

Wu Y, Liu B, Yan Y, Gong C, Wang K, Liu N Nat Commun. 2024; 15(1):10503.

PMID: 39627266 PMC: 11614905. DOI: 10.1038/s41467-024-54883-x.


Engineering Adhesion of the Probiotic Strain Nissle to the Fungal Pathogen .

Chamas A, Svensson C, Maneira C, Sporniak M, Figge M, Lackner G ACS Synth Biol. 2024; 13(12):4027-4039.

PMID: 39265099 PMC: 11669158. DOI: 10.1021/acssynbio.4c00466.


References
1.
Benjamin R, Graham C, Yallop D, Jozwik A, Mirci-Danicar O, Lucchini G . Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies. Lancet. 2020; 396(10266):1885-1894. PMC: 11773457. DOI: 10.1016/S0140-6736(20)32334-5. View

2.
McNerney M, Piorino F, Michel C, Styczynski M . Active Analyte Import Improves the Dynamic Range and Sensitivity of a Vitamin B Biosensor. ACS Synth Biol. 2020; 9(2):402-411. PMC: 7186122. DOI: 10.1021/acssynbio.9b00429. View

3.
Ye H, Xie M, Xue S, Hamri G, Yin J, Zulewski H . Self-adjusting synthetic gene circuit for correcting insulin resistance. Nat Biomed Eng. 2017; 1(1):0005. PMC: 5412959. DOI: 10.1038/s41551-016-0005. View

4.
Ajina A, Maher J . Prospects for combined use of oncolytic viruses and CAR T-cells. J Immunother Cancer. 2017; 5(1):90. PMC: 5696728. DOI: 10.1186/s40425-017-0294-6. View

5.
Citorik R, Mimee M, Lu T . Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol. 2014; 32(11):1141-5. PMC: 4237163. DOI: 10.1038/nbt.3011. View